Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu


Type 2 diabetes treatment pathways in New Zealand

Joyce Guo thumb

Tuesday 24 August 2021

A nationwide study by a medical student, Joyce Guo, and researchers from the Pharmacoepidemiology Research Network has found that real-world type 2 diabetes treatment patterns are complex and not always consistent with guidelines.

Dual treatment increases risk of heart attack – study

Jack Dummer and Lianne Parkin thumb

Friday 13 August 2021

People using two different inhalers for common chronic lung diseases are more than 50 per cent more likely to have a heart attack than those on just one, new University of Otago-led research reveals.

Long-acting bronchodilator use by patients with chronic lung disease and risk of acute coronary syndrome in real-world clinical practice

Lianna Parkin and Jack Drummer image 2021 thumb

Wednesday 27 January 2021

The use of two long-acting bronchodilator inhalers to treat chronic obstructive pulmonary disease (COPD) symptoms is associated with a higher risk of acute coronary syndrome (ACS, heart attack or unstable angina) than the use of just one long-acting bronchodilator according to recently published research by investigators from the Pharmacoepidemiology Research Network at the University of Otago.